Advertisement
Screener

Ghost Tree Capital, LLC Historic Quarter Change: USA Stocks, New, 2016 Q3

Ghost Tree Capital, LLC historic quarter change: USA Stocks, New

In share positions in stocks (listed in the US), over 14 quarters from 2013-12-31 to 2024-09-30, Ghost Tree Capital, LLC opened 144 positions, added to 89, reduced 77 and sold out of 127.

  • Q3 2016: Stock ZBH; Country of operation United States; Class COM; Shares before 0.
  • Q3 2016: Stock ABT; Country of operation United States; Class COM; Shares before 0.
  • Q3 2016: Stock PBYI; Country of operation United States; Class COM; Shares before 0.
  • Q3 2016: Stock PACB; Country of operation United States; Class COM; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595851), 14 quarters: Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-17); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-09); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2016ZBH
ZIMMER BIOMET HLDGS INC
United StatesCOM0125,000+125,000$0$16,253,000+$16,253,0002016-11-14
Q3 2016ABT
ABBOTT LABS
United StatesCOM0300,000+300,000$0$12,687,000+$12,687,0002016-11-14
Q3 2016PBYI
PUMA BIOTECHNOLOGY INC
United StatesCOM0150,000+150,000$0$10,058,000+$10,058,0002016-11-14
Q3 2016PACB
PACIFIC BIOSCIENCES CALIF IN
United StatesCOM0750,000+750,000$0$6,720,000+$6,720,0002016-11-14
Q3 2016ENTA
ENANTA PHARMACEUTICALS INC
United StatesCOM0250,000+250,000$0$6,653,000+$6,653,0002016-11-14
Q3 2016ACAD
ACADIA PHARMACEUTICALS INC
United StatesCOM0200,000+200,000$0$6,362,000+$6,362,0002016-11-14
Q3 2016ACRS
ACLARIS THERAPEUTICS INC
United StatesCOM0175,000+175,000$0$4,482,000+$4,482,0002016-11-14
Q3 2016TMO
THERMO FISHER SCIENTIFIC INC
United StatesCOM020,000+20,000$0$3,181,000+$3,181,0002016-11-14
Q3 2016EXAS
EXACT SCIENCES CORP
United StatesCOM0150,000+150,000$0$2,786,000+$2,786,0002016-11-14
Q3 2016AKBA
AKEBIA THERAPEUTICS INC
United StatesCOM0300,000+300,000$0$2,715,000+$2,715,0002016-11-14
Q3 2016XENE
XENON PHARMACEUTICALS INC
COM0325,000+325,000$0$2,633,000+$2,633,0002016-11-14
Q3 2016VNDA
VANDA PHARMACEUTICALS INC
United StatesCOM0111,000+111,000$0$1,847,000+$1,847,0002016-11-14
Q3 2016IONS
IONIS PHARMACEUTICALS INC
United StatesCOM025,000+25,000$0$916,000+$916,0002016-11-14

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet